The traders might have observed that the fall is much faster than the snail pace rise. The markets likely to witness the same kind of volatility till the HNI’s-deep pocked investors grab the early opportunity. The markets will fall but not more than 10% and create havoc in the minds of retail investor and pain in the heart.
The Nifty will not fall to 3200-300 levels as it fell from 5200 to this level. In case a sharp sell off from any సైడ్, market depth was shallow and it cannot take any out-right throw away sell-off.
The Nifty showed the required bull support to cross the 4093 level as posted in the morning but could not hold above 4073 level to give peace to the Bulls.
The Reliance (posted in the morning-The Reliance closed below 2020 level but for today it shall trade below 1990 so that the bears can make their day happy at this counter.) made a low of 1990 took support for this day abated the bears to make merry at the counter. The metals made a good come back across all counters and showed their strength. The RCOM failed to trade above 441-43 convincingly drifted to 435-36 level and Bharti didn’t hold the promise above 747. A surprise at the banking sector to many is that the Axis bank failed to cheer the street in spite of its robust quarterly numbers. The Ranbaxy sell off helps the Daiichi to buy the company with out raising the open offer.
Monday, July 14, 2008
Subscribe to:
Post Comments (Atom)
1 comment:
LONDON: Scientists attempting to create a nicotine pill to treat Alzheimer's disease have suggested that smoking can help boost memory and concentration.
Nicotine has long been known to have a stimulating effect on the brain. However, the deadly side effects of cancer, stroke and heart disease, mean its benefits have been largely set aside by medical research.
Now researchers, who hope to develop drugs which copy the active ingredients in tobacco without causing heart disease, cancer, stroke or addiction, discovered that nicotine can boost the intelligence and recall ability of animals in laboratory experiments.
The researchers, who plan to present their latest findings at the Forum of European Neuroscience in Geneva, hope that the new drugs, which will be available in five years, may have fewer side effects than existing medicines for dementia.
However, the scientists stressed the new treatment at best will only give patients a few extra months of independent life instead of fully freeing them of Alzheimer's disease.
"The substances that we call drugs have, in the majority of cases, do have a mixture of beneficial and harmful effects and nicotine no exception to this," Professor Ian Stoleman of Britain's King's College was quoted as saying by the Mail online.
Researchers led by Prof Stolerman studied how nicotine alters the brain's circuitry to boost concentration and memory. In his study, he showed that the concentration power in rats went up by 5 per cent when injected with nicotine, the report said.
Post a Comment